News Novo's next-gen diabetes drug could be best at cutting heart... Novo boosted by results from next-gen GLP-1.
Views & Analysis Digital Health Round-up – Verily's diabetes ambitions; IBM W... A round-up of this week’s top digital healthcare news. Marco Ricci reports.
Views & Analysis Google alliance Onduo central to Sanofi’s diabetes revival How will Onduo help Sanofi revive its diabetes business?
Views & Analysis Latin American healthcare: devices and technology Trends in diagnostic and patient monitoring devices, including wearables, mHealth apps and wireless technology.
News Google’s Verily and Sanofi create diabetes joint venture Onduo will aim to help people with diabetes live a full, healthy life.
News Court sides with EU on decision to revoke Ocaliva's license Advanz Pharma's bid to keep its Ocaliva treatment for rare liver disease primary biliary cholangitis (PBC) on the EU market has ended in failure
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
